| 英文别名 |
Flutamide;2-METHYL-N-(4'-NITRO-3'-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE;2-METHYL-N-(4-NITRO-3-[TRIFLUOROMETHYL]PHENYL)PROPANAMIDE;AURORA KA-860;N1-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]-2-METHYLPROPANAMIDE;TIMTEC-BB SBB006930;2-methyl-4’-nitro-alpha,alpha,alpha-triflouro-m-propionotoluidid;2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)-propanamid;4’-nitro-3’-trifluoromethylisobutyranilide;alpha,alpha,alpha-trifluoro-2-methyl-4’-nitro-m-propionotoluidide;niftholide;niftolide;sch13521;2-Methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]-propionamide;Flutamide USP25;FlutamideUsp27;N-[4-Nitro-3-(trifluoromethyl)phenyl]isoButyramide;FLUTAMIDE (2-METHYL-N-(4''-NITRO-3''-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE);Drognil;Euflex;2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide;Flutamide (SCH 13521,Flucinom, Flugerel, Niftolid, Flutamin®, Drogenil®, Eulexin®);FLUTAMIDE(P);[14C]-Flutamide;2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide,Flutamide;2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide;4'-Nitro-3'-(trifluoromethyl)isobutyranilide;4'-nitro-3'-trifluoromethylisobutyranilide;Drogenil;Eulexin;Flutamida;Flutamidum;NFBA;niftolid;Eunex;Odyne;Fugerel;Eu.1exim;Flucinom;氟他胺;Cebatrol, veterinary;Sch 13521;Flutamin;Flutamidum [INN-Latin];Flutamida [INN-Spanish];Flutamide(Eulexin);Flutamide (Eulexin);Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phe;37209-54-4;AB00052188_10;FLUTAMIDE [WHO-DD];EU-0100557;NC00451;m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-;F0663;Tox21_300536;Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-;NCGC00015452-12;KBio2_004258;CCG-39105;Prestwick2_000180;SPECTRUM1500995;AC-24192;FLUTAMIDE [EP IMPURITY];Spectrum5_001450;FLUTAMIDE [USP-RS];HY-B0022;SPBio_002000;EINECS 236-341-9;HMS3655G22;AKOS025243203;3'-Trifluoromethyl-4'-Nitro-Isobutyranilide;AKOS001025465;HMS3261P15;Z56755651;AB00052188;Flutamida (INN-Spanish);Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-;Prostandril;NCGC00254495-01;Spectrum4_000829;NCGC00015452-10;DTXSID7032004;F 9397;AB02835;HMS1921O16;HMS2090I18;Pharmakon1600-01500995;FLUTAMIDE (USP-RS);CPD000058187;Prestwick3_000180;Lopac0_000557;NCGC00015452-14;NCGC00015452-03;HMS3259I03;SW196536-4;KBio1_000459;FLUTAMIDE [JAN];Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard;NS00002675;Flutamidum (INN-Latin);N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE;Prestwick1_000180;KBio2_006826;NINDS_000459;NCGC00015452-11;CCRIS 7246;SR-01000075888-9;BCP23006;Flutamide,(S);s1908;BF166239;NCGC00015452-02;IDI1_000459;NCGC00015452-16;Spectrum3_001421;NCGC00015452-20;DTXCID9011121;SY036411;NCGC00015452-07;Chimax;m-Propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-;KBio2_001690;AB00052188-09;2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide #;SDCCGSBI-0050540.P004;alpha,alpha,alpha-trifluor... |